Status:
WITHDRAWN
Quality of Life and Target Achievement After Treatment of Patients With Stable Angina Pectoris
Lead Sponsor:
Göteborg University
Collaborating Sponsors:
Sahlgrenska University Hospital
Conditions:
Stable Angina Pectoris
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to, in patients with stable angina pectoris, assess the additional benefit of PCI on top of optimized medical treatment, physical training and smoking cessation with regar...
Detailed Description
Patients with stable angina pectoris with a significant coronary stenosis will be randomized to optimized medical treatment, physical training and smoking cessation or to optimized medical treatment, ...
Eligibility Criteria
Inclusion
- Stable coronary artery disease
- Angina pectoris with at least angina class 2 according to Canadian Cardiovascular Society (CCS)
- Angiographic verified stenos in a native vessel
- Accepted for PCI
Exclusion
- Instable coronary artery disease or AMI withín two months
- CCS class IV
- Stenosis in Left main and/or proximal LAD
- NYHA- III-IV
- Fall in blood pressure during exercise test \> 10mm Hg, measured two times
- Contraindication or allergy against clopidogrel or ASA
- Unable to communicate verbal or i writing
- Unwillingness to participate in the study
- Participating in an other study
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2010
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00825604
Start Date
January 1 2009
End Date
January 1 2010
Last Update
May 21 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sahlgrenska University hospital
Gothenburg, Sweden, 41345